Muscle volume alterations in spastic muscles immediately following botulinum toxin type‐A treatment in children with cerebral palsy

Citations Over TimeTop 10% of 2013 papers

Abstract

Muscle volume decreases were observed in the injected muscle (gastrocnemius), with synergistic muscle hypertrophy that appeared to compensate for this decrement. The 4% to 5% decrease in the volume of BoNT-A injected muscles are not dramatic in comparison to reports in recent animal studies, and are a positive indication for BoNT-A, particularly as it also did not negatively alter function.

Related Papers

• → Reflex hyperexcitability and muscle contracture in relation to spastic hypertonia(1996)132 cited
• → The Correlation between Gross Motor Function Classification System and Spasticity in Children with Cerebral Palsy(2021)8 cited
• The spastic mouse. And the search for an animal model of spasticity in human beings.(1990)
• [Treatment of spasticity with botulinum toxin].(1997)
• [Method of measuring spasticity. Studies of 12 cases of spastic patients treated with chronic epidural implanted electrodes].(1984)